MMDA-2
Rectal | |
| ATC code |
|
|---|---|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
JSmol) | |
| |
MMDA-2 (2-methoxy-4,5-methylenedioxyamphetamine) is a
appetite loss.[1] He states that 30 mg is very similar to 80 mg of MDA, and also remarks that it would be impossible for anyone to have a bad experience on the drug at that dose.[1]
Scientific research has shown that MMDA-2, unlike MMDA, but similarly to
6-methyl-MDA, is only very weak at inducing the release of serotonin or dopamine,[2] and accordingly, does not produce amphetamine-like responses in animals in drug discrimination studies.[3] Instead, MMDA-2 is likely to act as a pure 5-HT2 receptor agonist similarly to the DOx series of compounds, with activation of the 5-HT2A receptor conferring its psychedelic effects.[4]
MMDA-2 has been sold as a designer drug in Japan.[5]
See also
References
- ^ ISBN 978-0-9630096-0-9.
- S2CID 2740262.
- S2CID 5890314.
- S2CID 9948738.
- PMID 18789774.